Covered recipient · General Payments record
ANGELA M MERCER
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant Medical
General Payments · PY2021–2024
$4,542.29
- Reported across 228 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $620.12 | 33 |
| Education | $16.90 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| UCB, Inc. | $274.17 | 16 |
| ABBVIE INC. | $145.14 | 8 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $41.43 | 2 |
| Amgen Inc. | $30.66 | 1 |
| Dermavant Sciences, Inc. | $21.91 | 1 |
| Regeneron Healthcare Solutions, Inc. | $21.75 | 1 |
| Janssen Biotech, Inc. | $21.58 | 1 |
| Incyte Corporation | $18.82 | 1 |
| Arcutis Biotherapeutics, Inc. | $15.83 | 1 |
| Lilly USA, LLC | $15.63 | 1 |
| E.R. Squibb & Sons, L.L.C. | $15.06 | 1 |
| GENZYME CORPORATION | $15.04 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $27.91 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106984906 | CMS |
| ABBVIE INC. | $8.45 | 02/22/2024 | Education | Undisputed | 01/23/2026 | 1106984908 | CMS |
| ABBVIE INC. | $8.45 | 03/22/2024 | Education | Undisputed | 01/23/2026 | 1106984910 | CMS |
| ABBVIE INC. | $11.12 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106984912 | CMS |
| ABBVIE INC. | $34.69 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106984914 | CMS |
| ABBVIE INC. | $23.09 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106984916 | CMS |
| ABBVIE INC. | $7.52 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106984918 | CMS |
| ABBVIE INC. | $23.91 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106984920 | CMS |
| Amgen Inc. | $30.66 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117628588 | CMS |
| Arcutis Biotherapeutics, Inc. | $15.83 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1121083575 | CMS |
| Dermavant Sciences, Inc. | $21.91 | 06/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127966526 | CMS |
| E.R. Squibb & Sons, L.L.C. | $15.06 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101412665 | CMS |
| GENZYME CORPORATION | $15.04 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139778118 | CMS |
| Incyte Corporation | $18.82 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141317411 | CMS |
| Janssen Biotech, Inc. | $21.58 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078473502 | CMS |
| Lilly USA, LLC | $15.63 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135472091 | CMS |
| Novartis Pharmaceuticals Corporation | $13.33 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086901627 | CMS |
| Novartis Pharmaceuticals Corporation | $28.10 | 10/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086901639 | CMS |
| Regeneron Healthcare Solutions, Inc. | $21.75 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114290229 | CMS |
| UCB, Inc. | $10.87 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143146617 | CMS |
| UCB, Inc. | $7.80 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143146621 | CMS |
| UCB, Inc. | $11.34 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143146626 | CMS |
| UCB, Inc. | $18.31 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143146630 | CMS |
| UCB, Inc. | $10.75 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143147537 | CMS |
| UCB, Inc. | $16.19 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143147541 | CMS |
| UCB, Inc. | $13.40 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143147545 | CMS |
| UCB, Inc. | $7.38 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143147549 | CMS |
| UCB, Inc. | $0.81 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143147553 | CMS |
| UCB, Inc. | $0.97 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143147558 | CMS |
| UCB, Inc. | $1.20 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143147562 | CMS |
| UCB, Inc. | $13.58 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143147567 | CMS |
| UCB, Inc. | $124.21 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143147571 | CMS |
| UCB, Inc. | $17.99 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143147575 | CMS |
| UCB, Inc. | $4.92 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143147579 | CMS |
| UCB, Inc. | $14.45 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143147583 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.